Introduction
Patients at high risk of major complications, early death or late death after myocardial infarction can be easily recognized. The adverse prognostic factors Include previous myocardial infarction, age greater than 70 years, severe left ventricular failure, severe hypotension, cardiomegaly, bundle branch block, anterior wall infarction and very high levels of cardiac enzymes 1 , 2, 3. Although patients with none of the above have on the whole a good outlook, providing they survive to reach hospital, some will die or develop a major complication. Identification of this subset of at risk patients has received little attention. Total Creatine Phosphokinase (CPK) release after infarction can be related to infarct size and to prognosis 4 , 5, 6, 7, but the methodology involved in the investigation is too complex and cumbersome to be of use in a working coronary care unit. This study has attempted to relate peak CPK level as measured on a daily basis in the manner common to most coronary care units to prognosis in patients thought to be at low risk of death or major complications following acute myocardial infarction.
Method
Inclusion Criteria: Patients thought to be at low risk from death or major complications admitted to the coronary care unit because of definite myocardial infarction were enrolled into the study. Definite myocardial infarction was defined as typical pain lasting for at least 30 minutes plus elevation of CPK to at least three times the upper limits of normal, plus sequential ST and T wave changes of infarction or the development of Q waves of more than 30 milliseconds duration. Patients were assessed clinically on admission to the coronary care unit and blood was taken immediately for CPK assay. Serial CPK levels were taken for the next three days. Serial ECGs were recorded for at least the first three days and a chest x-ray was taken on admission and repeated there-after t as indicated. Patients were managed in the usual way except that IM injections, which were known , to elevate CPK, were avoided. Patients were followed to death or to six months from the day of admission. The following end points were noted:
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I Death 2 Ventricular fibrillation 3 Ventricular tachycardia (for the purpose of the study defined as aberrant ventricular complexes at a rate of greater than 120/min lasting for longer than 30 seconds). 4 Supraventricular tachycardias (including atrial fibrillation. 5 Left ventricular failure defined as chest x-ray evidence of pulmonary congestion plus a third heart sound, or chest x-ray evidence of pulmonary oedema. 6 High grade atrio ventricular block requiring treatment. 7 Angina after discharge. S A further cardiac event requiring re-admission to coronary care. Ninety-four consecutive patients with acute myocardial infarction without any major risk factors were enrolled into the study over a period of 12 months. They were divided into two groups. Group I with peak CPK levels of less than 1000 (23 patients) and Group II with peak CPK levels of more than 1000 (71 patients). The groups were closely similar with regard to age, sex, smoking habits, hypertension, angina, non insulin dependent diabetes and therapy with beta blockers or diuretics. The result of all patients are outlined in Table I . A total of 87 patients survived to leave hospital, of whom four subsequently died at home within the next six months. There was no significant difference in the rate of early death but deaths after seven days (Group I -0% versus Group 2 -10%, SE 3.6) and after discharge (Group I -0%
versus Group II -6 %, SE 2.8) were significantly more common in Group 11. Major arrhythmias were also significantly more frequent in Group II (Group I 17% versus Group 11 58%, SE 9.8). Left ventricular failure was significantly more common in Group II (Group I -9% versus Group II -38%, SE 8.3). Subset analysis of patients with anterior and inferior infarction was undertaken. In anterior infarction (Table IT) death, major arrhythmias and left ventricular failure remained closely associated with Group II patients. However, in patients with acute inferior infarction ( Table Ill) the association with left ventricular failure and arrhythmias was lost, although that with late death and supraventricular tachycardias remained. To exclude the possibility of falsely high CPK levels in Group 11 secondary to DC cardioversion (ventricular fibrillation was much more common in this group) a second subset analysis excluding patients with ventricular fibrillation was undertaken (Table IV) . Late death, major arrhythmias, other than ventricular fibrillation and left ventricular failure remained strongly associated with CPK level of greater than 1000 suggesting the association was not artefactual.
Discussion
Patients with poor prognosis after acute myocardial infarction can be identified by a variety of clinical and investigative parameters. Previous infarction, severe left ventricular failure, severe hypotension, bundle branch block, cardiomegaly advanced stage and gross elevation of cardiac enzymes especially total CPK are all adverse prognostic factors. Within the remaining patients who had none of the above and therefore who appear to be in low risk group, is a subset who develop major complications and have an increased mortality. Identifying this subgroup has proved difficult and has received relatively little attention. This study has attempted to evaluate the prognostic implications of peak CPK levels which are readily available in working coronary care units. A CPK of more than 1000 following myocardial infarction in patients with no adverse prognostic factors on admission seems to be significantly associated with the development of major arrhythmias, late death and left ventricular failure. Subset analysis has confirmed that the relationship remains strong when considering patients ~ith anterior myocardial infarction, but interestingly IS less definite with inferior infarction. This may be because death and complications after anterior infarction relates fairly closely to the amount of left ventricular muscle damaged, whereas an inferior infarction, frequently the right ventricle is also infarcted ca~sing se~ere haemodynamic ~pset, yet because of Its relatIvely small mass contributing little to total CPK release.
High. levels of CPK failed to predict angina after discha~ge from hospital nor did it predict further cardIac events (except death) requiring readmission to hospital. Peak CPK probably crudely reflects infarct size so the association with left ventricular failure, death and supraventricular arr~ythmi~s, which are particularly common in patients WIth elevated left ventricular and diastolic pressures is not surprising. Peak CPK cannot be used to predict risk from ventricular fibrillation because all the cases of ventricular fibrillation in this study occurred within the first 24 hours before peak CPKs were available. It can however, to some extent, predict those patients who will go on to develop left ventricular failure, and those at risk to death in the early hospital convalescent phase and in the late convalescent phase at home. This is of great importance with regard to rates of mobilization after apparently uncomplicated myocardial infarction and suggests that patients with very high levels of CPK should possibly be mobilized more carefully, and that their post discharge convalescence should be more gradual and return to work delayed beyond that normally recommended after uncomplicated infarction. It is particularly interesting to note that three of the four patients who died at home did not have any complications in hospital and had no other risk factors. Their prognosis was considered excellent. Although the figures are too small to draw conclusions and need to be confirmed by larger studies, it is tantalizing to think that such a simple test might identify the patients at risk to late sudden death, and have implications regarding the need for further investigation, in such individuals with a view to the introduction of preventive therapy.
